Internistische Gemeinschaftspraxis, Dr. Regner & Dr. Schmitt, Mainz Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2006
NCT00289510
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Internistische Gemeinschaftspraxis (Group practice for internal medicine) Dr. Regner & Dr. Schmitt, Mainz

Active Ingredients

Drugs in Phase 3 Trials (3)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

primaquine (1 trial)

Drugs in Phase 2 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 2)

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4